Premenstrual Syndrome Research Laboratory
is a corporation dedicated to the development of new medications for the
cure and prevention of the "PMS disease".
In January 1998 we obtained the registration
from the F.D.A. for our newest treatment "the 14th
Day Pill", which primarily treats one main symptom of PMS.
We are currently researching and developing more medications
for each of the other 72 symptoms.
Very soon we will be going public on this web page and
will be issuing shares prior to our IPO at a 10% discount.
If you are interested in investing in PMS Research Laboratory
Inc., please send us an e-mail.